• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶在儿童中的临床与药代动力学评价

[Clinical and pharmacokinetic evaluation of ceftazidime in children].

作者信息

Fujita K, Sakata H, Murono K, Yoshioka H, Maruyama S, Sanae N, Takimoto M

出版信息

Jpn J Antibiot. 1984 Mar;37(3):329-37.

PMID:6376845
Abstract

Forty-two pediatric patients were treated with ceftazidime ( CAZ ) in the doses ranging from 45.6 to 120 mg/kg/day for 2 to 10 days, and the clinical efficacy and side effects were evaluated. Among the 37 children with bacterial infections including pneumonia, bronchitis, tonsillitis, croup, cervical lymphadenitis, abdominal abscess and urinary tract infections, the results were excellent in 22, good in 12, fair in 2, and poor in 1 patient with pneumonia. Out of the 42 patients, 5 cases showed eosinophilia, but no clinical sign such as rash, fever or diarrhea, attributable to CAZ was observed during the study. The serum concentrations of CAZ in 4 patients ranged from 60.8 to 71.0 micrograms/ml (mean 66.1 micrograms/ml) at 30 minutes and from 0.5 to 1.2 micrograms/ml (mean 0.8 micrograms/ml) at 8 hours after 20 mg/kg intravenous bolus injection of the antibiotic. The mean serum half-life was 1.42 hours (85 minutes). Patients with impairment of renal function were excluded from this study.

摘要

42例儿科患者接受了头孢他啶(CAZ)治疗,剂量为45.6至120mg/kg/天,疗程2至10天,并对临床疗效和副作用进行了评估。在37例患有细菌感染(包括肺炎、支气管炎、扁桃体炎、哮吼、颈部淋巴结炎、腹部脓肿和尿路感染)的儿童中,22例效果极佳,12例良好,2例尚可,1例肺炎患者效果较差。42例患者中,5例出现嗜酸性粒细胞增多,但在研究期间未观察到与CAZ相关的皮疹、发热或腹泻等临床症状。4例患者在静脉推注20mg/kg抗生素后30分钟时,CAZ血清浓度为60.8至71.0微克/毫升(平均66.1微克/毫升),8小时时为0.5至1.2微克/毫升(平均0.8微克/毫升)。血清平均半衰期为1.42小时(85分钟)。肾功能损害患者被排除在本研究之外。

相似文献

1
[Clinical and pharmacokinetic evaluation of ceftazidime in children].头孢他啶在儿童中的临床与药代动力学评价
Jpn J Antibiot. 1984 Mar;37(3):329-37.
2
[Clinical evaluation of ceftazidime in paediatrics].
Jpn J Antibiot. 1984 Mar;37(3):524-36.
3
[Laboratory and clinical studies on ceftazidime in the field of pediatrics].头孢他啶在儿科领域的实验室及临床研究
Jpn J Antibiot. 1984 Mar;37(3):469-84.
4
[Fundamental and clinical studies of ceftazidime in the pediatric field].
Jpn J Antibiot. 1984 Mar;37(3):537-53.
5
[Clinical study on ceftazidime in the field of pediatrics].头孢他啶在儿科领域的临床研究
Jpn J Antibiot. 1984 Mar;37(3):377-88.
6
[Clinical evaluation of ceftazidime in the treatment of pediatric infections].头孢他啶治疗小儿感染的临床评估
Jpn J Antibiot. 1984 Mar;37(3):363-76.
7
[Clinical studies on ceftazidime in the pediatric field].
Jpn J Antibiot. 1984 Mar;37(3):349-54.
8
[Clinical and pharmacokinetic evaluation of ceftazidime in neonates and young infants].头孢他啶在新生儿和婴幼儿中的临床及药代动力学评价
Jpn J Antibiot. 1986 Aug;39(8):2068-76.
9
[Fundamental and clinical studies on ceftazidime in the field of pediatrics].头孢他啶在儿科领域的基础与临床研究
Jpn J Antibiot. 1984 Mar;37(3):490-511.
10
[Clinical and pharmacokinetic evaluation of ceftriaxone in children].头孢曲松在儿童中的临床及药代动力学评价
Jpn J Antibiot. 1984 Dec;37(12):2271-82.

引用本文的文献

1
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.